Document ID: chunk:federal_register_of_legislation:F2023L01174:reg:7
Version: federal_register_of_legislation:F2023L01174
Segment Type: reg
Provision Reference: reg 7
Character Range: 1742–3573

7               Kind of injury, disease or death to which this Statement of Principles relates
(1)          This Statement of Principles is about malignant neoplasm of the breast and death from malignant neoplasm of the breast.
Meaning of malignant neoplasm of the breast
(2)          For the purposes of this Statement of Principles, malignant neoplasm of the breast:
             (a)          means a primary malignant neoplasm arising from the epithelial cells of the breast of males and females; and
             (b)          includes:
(i)            carcinoma in situ; and
(ii)         Paget disease of the breast; and
             (c)          excludes:
(i)            haematolymphoid tumours including non-Hodgkin lymphoma and Hodgkin lymphoma;
(ii)         malignant melanoma; and
(iii)       mesenchymal tumours including soft tissue sarcoma.
(3)          While malignant neoplasm of the breast attracts ICD‑10‑AM code C50 or D05, in applying this Statement of Principles the meaning of malignant neoplasm of the breast is that given in subsection (2).
(4)          For subsection (3), a reference to an ICD-10-AM code is a reference to the code assigned to a particular kind of injury or disease in The International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification (ICD-10-AM), Tenth Edition, effective date of 1 July 2017, copyrighted by the Independent Hospital Pricing Authority, ISBN 978-1-76007-296-4.
Death from malignant neoplasm of the breast
(5)          For the purposes of this Statement of Principles, malignant neoplasm of the breast, in relation to a person, includes death from a terminal event or condition that was contributed to by the person's malignant neoplasm of the breast.
Note: terminal event is defined in the Schedule 1 – Dictionary.